ACTIVATED CLOTTING TIME AND HEPARIN MONITORING DURING CARDIOPULMONARY BYPASS

被引：0
|
作者：
SWAANENBURG, JCJM [1 ]
BRENKEN, U [1 ]
BAKKER, HAM [1 ]
机构：
[1] STATE UNIV GRONINGEN HOSP,9700 RB GRONINGEN,NETHERLANDS
来源：
CLINICAL CHEMISTRY | 1990年 / 36卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：975 / 975
页数：1
相关论文
共 50 条
  • [1] MONITORING HEPARIN AND PROTAMINE THERAPY DURING CARDIOPULMONARY BYPASS BY ACTIVATED CLOTTING TIME
    BERG, E
    STENBJERG, S
    ALBRECHTSEN, OK
    [J]. JOURNAL OF EXTRA-CORPOREAL TECHNOLOGY, 1979, 11 (06): : 229 - 235
  • [2] MONITORING HEPARIN BY THE ACTIVATED CLOTTING TIME WHEN APROTININ IS USED DURING CARDIOPULMONARY BYPASS
    HUNT, BJ
    SEGAL, H
    YACOUB, M
    [J]. THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1025 - 1025
  • [3] GUIDELINES FOR MONITORING HEPARIN BY THE ACTIVATED CLOTTING TIME WHEN APROTININ IS USED DURING CARDIOPULMONARY BYPASS
    HUNT, BJ
    SEGAL, HC
    YACOUB, M
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1992, 104 (01): : 211 - 212
  • [4] HEPARIN MONITORING DURING CARDIOPULMONARY BYPASS IN MAN - USE OF FLUOROGENIC HEPARIN ASSAY TO VALIDATE ACTIVATED CLOTTING TIME
    HUGHES, DR
    FAUST, RJ
    DIDISHEIM, P
    TINKER, JH
    [J]. ANESTHESIA AND ANALGESIA, 1982, 61 (02): : 189 - 190
  • [5] LACK OF CORRELATION BETWEEN ACTIVATED CLOTTING TIME AND PLASMA HEPARIN DURING CARDIOPULMONARY BYPASS
    CULLIFORD, AT
    GITEL, SN
    STARR, N
    THOMAS, ST
    BAUMANN, FG
    WESSLER, S
    SPENCER, FC
    [J]. ANNALS OF SURGERY, 1981, 193 (01) : 105 - 111
  • [6] Measurement of activated clotting time and whole blood heparin concentration during cardiopulmonary bypass
    Takashi Watanabe
    Kazuaki Shirota
    [J]. The Japanese Journal of Thoracic and Cardiovascular Surgery, 1998, 46 (6): : 530 - 530
  • [7] THE ROLE OF THE ACTIVATED CLOTTING TIME IN HEPARIN ADMINISTRATION AND NEUTRALIZATION FOR CARDIOPULMONARY BYPASS
    ESPOSITO, RA
    CULLIFORD, AT
    COLVIN, SB
    THOMAS, SJ
    LACKNER, H
    SPENCER, FC
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1983, 85 (02): : 174 - 185
  • [8] CLINICAL-EXPERIENCE WITH THE ACTIVATED CLOTTING TIME FOR THE CONTROL OF HEPARIN AND PROTAMINE THERAPY DURING CARDIOPULMONARY BYPASS
    AKL, BF
    VARGAS, GM
    NEAL, J
    ROBILLARD, J
    KELLY, P
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1980, 79 (01): : 97 - 102
  • [9] Extrinsic pathway-associated activated clotting time for anticoagulation monitoring during cardiopulmonary bypass
    Gu, YJ
    Huyzen, RJ
    vanOeveren, W
    [J]. ANESTHESIA AND ANALGESIA, 1996, 83 (02): : 433 - 433
  • [10] Factors influencing activated clotting time following heparin administration for the initiation of cardiopulmonary bypass
    Matsushita, Satoshi
    Kishida, Akinori
    Wakamatsu, Yoshihito
    Mukaida, Hiroshi
    Yokokawa, Hirohide
    Yamamoto, Taira
    Amano, Atsushi
    [J]. GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2021, 69 (01) : 38 - 43
12345